Cargando…
Predictive Value of the CHA(2)DS(2)-VASc Score for Mortality in Hospitalized Acute Coronary Syndrome Patients With Chronic Kidney Disease
BACKGROUND: Chronic kidney disease (CKD) patients have a high prevalence of coronary artery disease and a high risk of cardiovascular events. The present study assessed the value of the CHA(2)DS(2)-VASc score for predicting mortality among hospitalized acute coronary syndrome (ACS) patients with CKD...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965867/ https://www.ncbi.nlm.nih.gov/pubmed/35369355 http://dx.doi.org/10.3389/fcvm.2022.790193 |
_version_ | 1784678528844824576 |
---|---|
author | Wu, Yaxin Gao, Yanxiang Li, Qing Wu, Chao Xie, Enmin Tu, Yimin Guo, Ziyu Ye, Zixiang Li, Peizhao Li, Yike Yu, Xiaozhai Ren, Jingyi Zheng, Jingang |
author_facet | Wu, Yaxin Gao, Yanxiang Li, Qing Wu, Chao Xie, Enmin Tu, Yimin Guo, Ziyu Ye, Zixiang Li, Peizhao Li, Yike Yu, Xiaozhai Ren, Jingyi Zheng, Jingang |
author_sort | Wu, Yaxin |
collection | PubMed |
description | BACKGROUND: Chronic kidney disease (CKD) patients have a high prevalence of coronary artery disease and a high risk of cardiovascular events. The present study assessed the value of the CHA(2)DS(2)-VASc score for predicting mortality among hospitalized acute coronary syndrome (ACS) patients with CKD. METHODS: This was a retrospective cohort study that included CKD patients who were hospitalized for ACS from January 2015 to May 2020. The CHA(2)DS(2)-VASc score for each eligible patient was determined. Patients were stratified into two groups according to CHA(2)DS(2)-VASc score: <6 (low) and ≥6 (high). The primary endpoint was all-cause mortality. RESULTS: A total of 313 eligible patients were included in the study, with a mean CHA(2)DS(2)-VASC score of 4.55 ± 1.68. A total of 220 and 93 patients were assigned to the low and high CHA(2)DS(2)-VASc score groups, respectively. The most common reason for hospitalization was unstable angina (39.3%), followed by non-ST-elevation myocardial infarction (35.8%) and ST-elevation myocardial infarction (24.9%). A total of 67.7% of the patients (212/313) received coronary reperfusion therapy during hospitalization. The median follow-up time was 23.0 months (interquartile range: 12–38 months). A total of 94 patients (30.0%) died during follow-up. The high score group had a higher mortality rate than the low score group (46.2 vs. 23.2%, respectively; p < 0.001). The cumulative incidence of all-cause death was higher in the high score group than in the low score group (Log-rank test, p < 0.001). Multivariate Cox regression analysis indicated that CHA(2)DS(2)-VASc scores were positively associated with all-cause mortality (hazard ratio: 2.02, 95% confidence interval: 1.26–3.27, p < 0.001). CONCLUSION: The CHA(2)DS(2)-VASc score is an independent predictive factor for all-cause mortality in CKD patients who are hospitalized with ACS. This simple and practical scoring system may be useful for the early identification of patients with a high risk of death. |
format | Online Article Text |
id | pubmed-8965867 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89658672022-03-31 Predictive Value of the CHA(2)DS(2)-VASc Score for Mortality in Hospitalized Acute Coronary Syndrome Patients With Chronic Kidney Disease Wu, Yaxin Gao, Yanxiang Li, Qing Wu, Chao Xie, Enmin Tu, Yimin Guo, Ziyu Ye, Zixiang Li, Peizhao Li, Yike Yu, Xiaozhai Ren, Jingyi Zheng, Jingang Front Cardiovasc Med Cardiovascular Medicine BACKGROUND: Chronic kidney disease (CKD) patients have a high prevalence of coronary artery disease and a high risk of cardiovascular events. The present study assessed the value of the CHA(2)DS(2)-VASc score for predicting mortality among hospitalized acute coronary syndrome (ACS) patients with CKD. METHODS: This was a retrospective cohort study that included CKD patients who were hospitalized for ACS from January 2015 to May 2020. The CHA(2)DS(2)-VASc score for each eligible patient was determined. Patients were stratified into two groups according to CHA(2)DS(2)-VASc score: <6 (low) and ≥6 (high). The primary endpoint was all-cause mortality. RESULTS: A total of 313 eligible patients were included in the study, with a mean CHA(2)DS(2)-VASC score of 4.55 ± 1.68. A total of 220 and 93 patients were assigned to the low and high CHA(2)DS(2)-VASc score groups, respectively. The most common reason for hospitalization was unstable angina (39.3%), followed by non-ST-elevation myocardial infarction (35.8%) and ST-elevation myocardial infarction (24.9%). A total of 67.7% of the patients (212/313) received coronary reperfusion therapy during hospitalization. The median follow-up time was 23.0 months (interquartile range: 12–38 months). A total of 94 patients (30.0%) died during follow-up. The high score group had a higher mortality rate than the low score group (46.2 vs. 23.2%, respectively; p < 0.001). The cumulative incidence of all-cause death was higher in the high score group than in the low score group (Log-rank test, p < 0.001). Multivariate Cox regression analysis indicated that CHA(2)DS(2)-VASc scores were positively associated with all-cause mortality (hazard ratio: 2.02, 95% confidence interval: 1.26–3.27, p < 0.001). CONCLUSION: The CHA(2)DS(2)-VASc score is an independent predictive factor for all-cause mortality in CKD patients who are hospitalized with ACS. This simple and practical scoring system may be useful for the early identification of patients with a high risk of death. Frontiers Media S.A. 2022-03-16 /pmc/articles/PMC8965867/ /pubmed/35369355 http://dx.doi.org/10.3389/fcvm.2022.790193 Text en Copyright © 2022 Wu, Gao, Li, Wu, Xie, Tu, Guo, Ye, Li, Li, Yu, Ren and Zheng. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Wu, Yaxin Gao, Yanxiang Li, Qing Wu, Chao Xie, Enmin Tu, Yimin Guo, Ziyu Ye, Zixiang Li, Peizhao Li, Yike Yu, Xiaozhai Ren, Jingyi Zheng, Jingang Predictive Value of the CHA(2)DS(2)-VASc Score for Mortality in Hospitalized Acute Coronary Syndrome Patients With Chronic Kidney Disease |
title | Predictive Value of the CHA(2)DS(2)-VASc Score for Mortality in Hospitalized Acute Coronary Syndrome Patients With Chronic Kidney Disease |
title_full | Predictive Value of the CHA(2)DS(2)-VASc Score for Mortality in Hospitalized Acute Coronary Syndrome Patients With Chronic Kidney Disease |
title_fullStr | Predictive Value of the CHA(2)DS(2)-VASc Score for Mortality in Hospitalized Acute Coronary Syndrome Patients With Chronic Kidney Disease |
title_full_unstemmed | Predictive Value of the CHA(2)DS(2)-VASc Score for Mortality in Hospitalized Acute Coronary Syndrome Patients With Chronic Kidney Disease |
title_short | Predictive Value of the CHA(2)DS(2)-VASc Score for Mortality in Hospitalized Acute Coronary Syndrome Patients With Chronic Kidney Disease |
title_sort | predictive value of the cha(2)ds(2)-vasc score for mortality in hospitalized acute coronary syndrome patients with chronic kidney disease |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965867/ https://www.ncbi.nlm.nih.gov/pubmed/35369355 http://dx.doi.org/10.3389/fcvm.2022.790193 |
work_keys_str_mv | AT wuyaxin predictivevalueofthecha2ds2vascscoreformortalityinhospitalizedacutecoronarysyndromepatientswithchronickidneydisease AT gaoyanxiang predictivevalueofthecha2ds2vascscoreformortalityinhospitalizedacutecoronarysyndromepatientswithchronickidneydisease AT liqing predictivevalueofthecha2ds2vascscoreformortalityinhospitalizedacutecoronarysyndromepatientswithchronickidneydisease AT wuchao predictivevalueofthecha2ds2vascscoreformortalityinhospitalizedacutecoronarysyndromepatientswithchronickidneydisease AT xieenmin predictivevalueofthecha2ds2vascscoreformortalityinhospitalizedacutecoronarysyndromepatientswithchronickidneydisease AT tuyimin predictivevalueofthecha2ds2vascscoreformortalityinhospitalizedacutecoronarysyndromepatientswithchronickidneydisease AT guoziyu predictivevalueofthecha2ds2vascscoreformortalityinhospitalizedacutecoronarysyndromepatientswithchronickidneydisease AT yezixiang predictivevalueofthecha2ds2vascscoreformortalityinhospitalizedacutecoronarysyndromepatientswithchronickidneydisease AT lipeizhao predictivevalueofthecha2ds2vascscoreformortalityinhospitalizedacutecoronarysyndromepatientswithchronickidneydisease AT liyike predictivevalueofthecha2ds2vascscoreformortalityinhospitalizedacutecoronarysyndromepatientswithchronickidneydisease AT yuxiaozhai predictivevalueofthecha2ds2vascscoreformortalityinhospitalizedacutecoronarysyndromepatientswithchronickidneydisease AT renjingyi predictivevalueofthecha2ds2vascscoreformortalityinhospitalizedacutecoronarysyndromepatientswithchronickidneydisease AT zhengjingang predictivevalueofthecha2ds2vascscoreformortalityinhospitalizedacutecoronarysyndromepatientswithchronickidneydisease |